nodes	percent_of_prediction	percent_of_DWPC	metapath
Levocabastine—Ocular hyperaemia—Tretinoin—peripheral nervous system neoplasm	0.0384	0.048	CcSEcCtD
Levocabastine—Ocular hyperaemia—Isotretinoin—peripheral nervous system neoplasm	0.0384	0.048	CcSEcCtD
Levocabastine—Ocular hyperaemia—Alitretinoin—peripheral nervous system neoplasm	0.0291	0.0364	CcSEcCtD
Levocabastine—Stinging—Tretinoin—peripheral nervous system neoplasm	0.0222	0.0278	CcSEcCtD
Levocabastine—Stinging—Isotretinoin—peripheral nervous system neoplasm	0.0222	0.0278	CcSEcCtD
Levocabastine—Lacrimation increased—Tretinoin—peripheral nervous system neoplasm	0.0195	0.0244	CcSEcCtD
Levocabastine—Lacrimation increased—Isotretinoin—peripheral nervous system neoplasm	0.0195	0.0244	CcSEcCtD
Levocabastine—NTSR2—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.0171	0.0854	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.0169	0.0843	CbGpPWpGaD
Levocabastine—Stinging—Alitretinoin—peripheral nervous system neoplasm	0.0168	0.021	CcSEcCtD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.0153	0.0764	CbGpPWpGaD
Levocabastine—Lacrimation increased—Alitretinoin—peripheral nervous system neoplasm	0.0148	0.0185	CcSEcCtD
Levocabastine—Visual disturbance—Tretinoin—peripheral nervous system neoplasm	0.0138	0.0172	CcSEcCtD
Levocabastine—Visual disturbance—Isotretinoin—peripheral nervous system neoplasm	0.0138	0.0172	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.0113	0.0566	CbGpPWpGaD
Levocabastine—Visual disturbance—Alitretinoin—peripheral nervous system neoplasm	0.0104	0.0131	CcSEcCtD
Levocabastine—Lacrimation—Epirubicin—peripheral nervous system neoplasm	0.0101	0.0127	CcSEcCtD
Levocabastine—Lacrimation—Doxorubicin—peripheral nervous system neoplasm	0.00939	0.0117	CcSEcCtD
Levocabastine—Pharyngitis—Topotecan—peripheral nervous system neoplasm	0.00904	0.0113	CcSEcCtD
Levocabastine—Pharyngitis—Tretinoin—peripheral nervous system neoplasm	0.00897	0.0112	CcSEcCtD
Levocabastine—Pharyngitis—Isotretinoin—peripheral nervous system neoplasm	0.00897	0.0112	CcSEcCtD
Levocabastine—Visual impairment—Isotretinoin—peripheral nervous system neoplasm	0.0087	0.0109	CcSEcCtD
Levocabastine—Visual impairment—Tretinoin—peripheral nervous system neoplasm	0.0087	0.0109	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00863	0.0431	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00828	0.0413	CbGpPWpGaD
Levocabastine—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00786	0.00983	CcSEcCtD
Levocabastine—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00786	0.00983	CcSEcCtD
Levocabastine—NTSR2—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00769	0.0384	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00759	0.0379	CbGpPWpGaD
Levocabastine—Stinging—Epirubicin—peripheral nervous system neoplasm	0.00736	0.00921	CcSEcCtD
Levocabastine—Pharyngitis—Dactinomycin—peripheral nervous system neoplasm	0.00733	0.00916	CcSEcCtD
Levocabastine—Cough—Topotecan—peripheral nervous system neoplasm	0.00692	0.00865	CcSEcCtD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.00688	0.0343	CbGpPWpGaD
Levocabastine—Cough—Isotretinoin—peripheral nervous system neoplasm	0.00686	0.00858	CcSEcCtD
Levocabastine—Cough—Tretinoin—peripheral nervous system neoplasm	0.00686	0.00858	CcSEcCtD
Levocabastine—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.00681	0.00852	CcSEcCtD
Levocabastine—Pharyngitis—Alitretinoin—peripheral nervous system neoplasm	0.00679	0.0085	CcSEcCtD
Levocabastine—Cough—Melphalan—peripheral nervous system neoplasm	0.00677	0.00847	CcSEcCtD
Levocabastine—Visual impairment—Alitretinoin—peripheral nervous system neoplasm	0.0066	0.00825	CcSEcCtD
Levocabastine—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00655	0.00819	CcSEcCtD
Levocabastine—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00655	0.00819	CcSEcCtD
Levocabastine—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.00647	0.00809	CcSEcCtD
Levocabastine—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00643	0.00804	CcSEcCtD
Levocabastine—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.00599	0.00749	CcSEcCtD
Levocabastine—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00596	0.00745	CcSEcCtD
Levocabastine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00577	0.00721	CcSEcCtD
Levocabastine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00572	0.00716	CcSEcCtD
Levocabastine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00572	0.00716	CcSEcCtD
Levocabastine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00571	0.00713	CcSEcCtD
Levocabastine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00571	0.00713	CcSEcCtD
Levocabastine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00565	0.00706	CcSEcCtD
Levocabastine—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.00562	0.00703	CcSEcCtD
Levocabastine—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00558	0.00698	CcSEcCtD
Levocabastine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00553	0.00692	CcSEcCtD
Levocabastine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00553	0.00692	CcSEcCtD
Levocabastine—Pain—Topotecan—peripheral nervous system neoplasm	0.00553	0.00692	CcSEcCtD
Levocabastine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00549	0.00686	CcSEcCtD
Levocabastine—Pain—Tretinoin—peripheral nervous system neoplasm	0.00549	0.00686	CcSEcCtD
Levocabastine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00546	0.00683	CcSEcCtD
Levocabastine—Pain—Melphalan—peripheral nervous system neoplasm	0.00542	0.00677	CcSEcCtD
Levocabastine—Cough—Alitretinoin—peripheral nervous system neoplasm	0.0052	0.0065	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00509	0.0254	CbGpPWpGaD
Levocabastine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00508	0.00635	CcSEcCtD
Levocabastine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00496	0.00621	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00488	0.0243	CbGpPWpGaD
Levocabastine—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.0048	0.006	CcSEcCtD
Levocabastine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00464	0.0058	CcSEcCtD
Levocabastine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.0046	0.00576	CcSEcCtD
Levocabastine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.0046	0.00576	CcSEcCtD
Levocabastine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00454	0.00568	CcSEcCtD
Levocabastine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00452	0.00566	CcSEcCtD
Levocabastine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00449	0.00561	CcSEcCtD
Levocabastine—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.00444	0.00555	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00443	0.0221	CbGpPWpGaD
Levocabastine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00434	0.00542	CcSEcCtD
Levocabastine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00432	0.00541	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00425	0.0212	CbGpPWpGaD
Levocabastine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00419	0.00524	CcSEcCtD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.00418	0.0209	CbGpPWpGaD
Levocabastine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00416	0.0052	CcSEcCtD
Levocabastine—Rash—Topotecan—peripheral nervous system neoplasm	0.00408	0.0051	CcSEcCtD
Levocabastine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00408	0.0051	CcSEcCtD
Levocabastine—Cough—Etoposide—peripheral nervous system neoplasm	0.00406	0.00508	CcSEcCtD
Levocabastine—Headache—Topotecan—peripheral nervous system neoplasm	0.00405	0.00507	CcSEcCtD
Levocabastine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00405	0.00506	CcSEcCtD
Levocabastine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00405	0.00506	CcSEcCtD
Levocabastine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00404	0.00506	CcSEcCtD
Levocabastine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00404	0.00506	CcSEcCtD
Levocabastine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00404	0.00505	CcSEcCtD
Levocabastine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00402	0.00503	CcSEcCtD
Levocabastine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00402	0.00503	CcSEcCtD
Levocabastine—Pain—Vincristine—peripheral nervous system neoplasm	0.00401	0.00501	CcSEcCtD
Levocabastine—Rash—Melphalan—peripheral nervous system neoplasm	0.00399	0.00499	CcSEcCtD
Levocabastine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00399	0.00499	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00388	0.0194	CbGpPWpGaD
Levocabastine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00384	0.00481	CcSEcCtD
Levocabastine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00381	0.00477	CcSEcCtD
Levocabastine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00381	0.00477	CcSEcCtD
Levocabastine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00376	0.00471	CcSEcCtD
Levocabastine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00376	0.00471	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.0037	0.0185	CbGpPWpGaD
Levocabastine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00369	0.00462	CcSEcCtD
Levocabastine—Pain—Cisplatin—peripheral nervous system neoplasm	0.00354	0.00443	CcSEcCtD
Levocabastine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00349	0.00436	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00339	0.0169	CbGpPWpGaD
Levocabastine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00338	0.00423	CcSEcCtD
Levocabastine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00337	0.00422	CcSEcCtD
Levocabastine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00336	0.0042	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00336	0.0168	CbGpPWpGaD
Levocabastine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00331	0.00414	CcSEcCtD
Levocabastine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00327	0.00409	CcSEcCtD
Levocabastine—Pain—Etoposide—peripheral nervous system neoplasm	0.00325	0.00406	CcSEcCtD
Levocabastine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00312	0.0039	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.0031	0.0155	CbGpPWpGaD
Levocabastine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00307	0.00383	CcSEcCtD
Levocabastine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00306	0.00383	CcSEcCtD
Levocabastine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00305	0.00381	CcSEcCtD
Levocabastine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00297	0.00372	CcSEcCtD
Levocabastine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00297	0.00372	CcSEcCtD
Levocabastine—Rash—Vincristine—peripheral nervous system neoplasm	0.00295	0.0037	CcSEcCtD
Levocabastine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00295	0.00369	CcSEcCtD
Levocabastine—Headache—Vincristine—peripheral nervous system neoplasm	0.00294	0.00367	CcSEcCtD
Levocabastine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00289	0.00361	CcSEcCtD
Levocabastine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00289	0.00361	CcSEcCtD
Levocabastine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00278	0.00348	CcSEcCtD
Levocabastine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00275	0.00344	CcSEcCtD
Levocabastine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00272	0.00341	CcSEcCtD
Levocabastine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00267	0.00334	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00262	0.0131	CbGpPWpGaD
Levocabastine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00261	0.00327	CcSEcCtD
Levocabastine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00261	0.00326	CcSEcCtD
Levocabastine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00261	0.00326	CcSEcCtD
Levocabastine—HRH1—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.0026	0.013	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.00251	0.0125	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00251	0.0125	CbGpPWpGaD
Levocabastine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00246	0.00308	CcSEcCtD
Levocabastine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00241	0.00302	CcSEcCtD
Levocabastine—Rash—Etoposide—peripheral nervous system neoplasm	0.00239	0.00299	CcSEcCtD
Levocabastine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00239	0.00299	CcSEcCtD
Levocabastine—HRH1—IL-4 Signaling Pathway—BIRC5—peripheral nervous system neoplasm	0.00239	0.0119	CbGpPWpGaD
Levocabastine—Headache—Etoposide—peripheral nervous system neoplasm	0.00238	0.00297	CcSEcCtD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00232	0.0116	CbGpPWpGaD
Levocabastine—Cough—Epirubicin—peripheral nervous system neoplasm	0.00228	0.00285	CcSEcCtD
Levocabastine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00226	0.00282	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.00219	0.0109	CbGpPWpGaD
Levocabastine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00217	0.00272	CcSEcCtD
Levocabastine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.00211	0.00263	CcSEcCtD
Levocabastine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00201	0.00251	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00199	0.00993	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00198	0.0099	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00192	0.00957	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.00191	0.00956	CbGpPWpGaD
Levocabastine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.0019	0.00237	CcSEcCtD
Levocabastine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00189	0.00237	CcSEcCtD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.00184	0.00918	CbGpPWpGaD
Levocabastine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00229	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00183	0.00913	CbGpPWpGaD
Levocabastine—Pain—Epirubicin—peripheral nervous system neoplasm	0.00182	0.00228	CcSEcCtD
Levocabastine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.0022	CcSEcCtD
Levocabastine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00175	0.00219	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00174	0.00869	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00172	0.00858	CbGpPWpGaD
Levocabastine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.0017	0.00212	CcSEcCtD
Levocabastine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00168	0.00211	CcSEcCtD
Levocabastine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00153	0.00191	CcSEcCtD
Levocabastine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00141	0.00177	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.00137	0.00686	CbGpPWpGaD
Levocabastine—Rash—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00168	CcSEcCtD
Levocabastine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00168	CcSEcCtD
Levocabastine—Headache—Epirubicin—peripheral nervous system neoplasm	0.00133	0.00167	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00131	0.00653	CbGpPWpGaD
Levocabastine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00158	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00126	0.00627	CbGpPWpGaD
Levocabastine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00155	CcSEcCtD
Levocabastine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00155	CcSEcCtD
Levocabastine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.00154	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.00121	0.00604	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00118	0.00587	CbGpPWpGaD
Levocabastine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00146	CcSEcCtD
Levocabastine—HRH1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00117	0.00582	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00112	0.00559	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.00104	0.00521	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00103	0.00513	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000773	0.00386	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000744	0.00371	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00074	0.00369	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000727	0.00363	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000715	0.00357	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000672	0.00335	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000644	0.00322	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000634	0.00316	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000588	0.00294	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000565	0.00282	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000561	0.0028	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000532	0.00266	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000517	0.00258	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000514	0.00257	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000513	0.00256	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000509	0.00254	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00047	0.00235	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.00047	0.00234	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00043	0.00214	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.0004	0.002	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000397	0.00198	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000381	0.0019	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000381	0.0019	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000332	0.00166	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000329	0.00164	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000314	0.00157	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000302	0.00151	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000301	0.0015	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000291	0.00145	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000279	0.00139	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000278	0.00139	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000278	0.00139	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000264	0.00132	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000209	0.00104	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000183	0.000916	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000178	0.00089	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00017	0.000848	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000156	0.000778	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.00011	0.000551	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000108	0.000541	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.57e-05	0.000428	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.07e-05	0.000403	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.85e-05	0.000392	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.78e-05	0.000388	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.13e-05	0.000356	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.52e-05	0.000325	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.07e-05	0.000303	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.99e-05	0.000249	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.77e-05	0.000238	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.21e-05	0.00021	CbGpPWpGaD
